Our amazing Data and Program Manager, Lexi Dyer, is heading to UCLA to start her PhD in Epidemiology! We’re sad to see her go, but we are cheering her on every step of the way. Thanks for everything, Lexi—we can’t wait to see what you accomplish next! https://t.co/9HLZddZ8TU
What does it take to investigate the effect of drug treatments on parasitic worms in the human body? Learn how the DOLF team collaborates across three continents in our quest to uncover which drugs work best to treat and eliminate onchocerciasis. https://t.co/xo8K0asn7v
Congratulations to Gina Haida for receiving the inaugural WashU Med Infectious Diseases Division Unsung Hero Award! Your constant dedication and decades of experience are essential to our success! @WashUMedID
The efficacy phase of our clinical trial in Liberia is underway. Members of our WashU team traveled to Bong Mines to work with our field and surgical team to prepare for the nodulectomy stage. Read more: https://t.co/NuwdXvKVBT
Congratulations to DOLF postdoc, Dr. Matthew Kulpa for receiving the Graduate Student Award in Zoonotic Disease at the @AAVParasit annual conference! Read more about his research here: https://t.co/PBxq1MgrQ6
Congratulations to Gina Haida for 30 years of service at WashU! Gina has been with DOLF since day one 15+ years ago and has been instrumental in the success of our global work. We are so thankful for you, Gina! Congratulations on this impressive milestone!
DOLF has reached a massive project milestone! We've begun removing participants' onchocercal nodules, which is the primary endpoint of our study. This minor surgery not only provides valuable data on the efficacy of moxidectin, but also allows our participants to live nodule-free
DOLF researchers recently revisited a small island in Indonesia 20 years later to uncover whether MDA was successful in eliminating LF. Take a deep dive into the story two decades in the making in the newest issue of Washington Magazine: https://t.co/V287TGl7D1
The DOLF project recently celebrated 15 years of conducting clinical and translational research to test new treatments to support the elimination of oncho and LF! A review of our progress, discoveries, and hopes for the future can be found here: https://t.co/xA9WynQ1sS
The Molecular Helminthology Lab welcomed a new postdoc last month! We're excited for Matthew Kulpa to join the team and are looking forward to seeing his accomplishments! https://t.co/AWh83jx40c
Farewell & best wishes to our DOLF postdoc, Irina Diekmann! We thank Irina for her outstanding work and wish her every success in the next chapter of her career. Read more about her scientific contributions here: https://t.co/RYXJ0FwdMY
This week, DOLF Senior Scientist, Kerstin Fischer, traveled to Côte d'Ivoire to train researchers from @CSRS_CIV in molecular xenomontoring techniques. These skills will be used to help understand the impact of MDA on oncho prevalence in blackflies.
Happy 2026 from DOLF! As we reflect on the year 2025, the DOLF team recognizes a period marked by continued scientific rigor, collaboration, and progress toward the elimination of onchocerciasis and lymphatic filariasis. See our year in review here: https://t.co/ixIUnmqNAt
We are pleased to share @Merck's announcement that the donation of Mectizan to accelerate the elimination of lymphatic filariasis will be extended through 2030 in alignment with the @WHO Neglected Tropical Diseases Road Map. #EliminateLF#beatNTDs
https://t.co/nlZiY7y5pK
Check out our new DOLF publication! This study demonstrates that semi-annual and annual DEC and albendazole are both equally effective treatments for LF in Papua New Guinea. Read more about this discovery here: https://t.co/JQEp36zz0V
DOLF had a successful trip to @ASTMH 2025! Many engaging presentations, lively conversations, and discussions about the future of NTD treatment and elimination. Thanks to all the collaborators that we connected with in Toronto. Let's keep this important work going!